Wedbush Reiterates Outperform on Tyra Biosciences, Maintains $27 Price Target
Portfolio Pulse from richadhand@benzinga.com
Wedbush analyst Robert Driscoll has reiterated an Outperform rating on Tyra Biosciences (NASDAQ:TYRA) and maintained a $27 price target.
August 11, 2023 | 2:41 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Wedbush analyst has reiterated an Outperform rating on Tyra Biosciences and maintained a $27 price target.
The reiteration of an Outperform rating by a reputable analyst like Robert Driscoll from Wedbush is a positive signal for Tyra Biosciences. The maintained price target of $27 also indicates confidence in the company's stock performance. This could potentially lead to an increase in the stock's price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100